RecruitingNCT06072898
Psilocybin and brain networks related to mood and depression
About this title
Read the official source — NCT06072898Medication studyAges 18–64Canada
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 64 years. Other eligibility criteria apply.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 28, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 50
- Sponsor
- Sunnybrook Health Sciences Centre
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT06072898
- Official title
Show the full official title
Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sunnybrook Health Sciences Centre.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 64 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
